Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lucira Health Inc LHDXQ

Lucira Health, Inc. is a United States-based company. The Company has no business operations and is in liquidation.

Recent & Breaking News (GREY:LHDXQ)

Lucira Health Announces U.S. Launch of First & Only At-Home Combination COVID-19 & Flu Test Amidst Sale Process

GlobeNewswire March 28, 2023

Lucira Health Announces FDA Authorization of First & Only At-Home Combination Covid-19 & Flu Test and Comments on Chapter 11 Bankruptcy Filing

GlobeNewswire February 27, 2023

Lucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process

GlobeNewswire February 22, 2023

SESAME PARTNERS WITH LUCIRA HEALTH AS OFFICIAL TELEHEALTH PROVIDER OF LAB-QUALITY TEST-TO-TREAT PROGRAM

PR Newswire January 5, 2023

Lucira Health Launches Lucira Connect, a Free Test-to-Treat Telehealth Service for Covid-19 or Flu in Canada

GlobeNewswire January 4, 2023

Lucira Health Submits EUA for Over-The-Counter (OTC) Use of its COVID-19 & Flu Test

GlobeNewswire January 3, 2023

Lucira and Loch Lomond Villa Announce Clinical Study to Tackle Tripledemic With First and Only Combination COVID-19 and Flu OTC Molecular Self-Test

GlobeNewswire December 6, 2022

Lucira Health Announces FDA Authorization of Combination COVID-19 & Flu Test at Point-of-Care

GlobeNewswire November 22, 2022

Lucira Health Announces National Launch of Lucira Connect Test-to-Treat Service

GlobeNewswire November 17, 2022

Lucira Health Announces Third Quarter 2022 Results and Provides Business Updates

GlobeNewswire November 14, 2022

Lucira Health to Announce Third Quarter 2022 Financial Results

GlobeNewswire November 1, 2022

Lucira Health Reports Pilot Study Interim Results for Chlamydia and Gonorrhea Assays

GlobeNewswire September 29, 2022

Lucira Health to Participate in LifeSci Partners HealthTech Symposium

GlobeNewswire September 7, 2022

Lucira Health to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

GlobeNewswire August 23, 2022

Lucira Health Announces Second Quarter 2022 Results and Provides Business Updates

GlobeNewswire August 15, 2022

Lucira Announces Health Canada Authorization of First and Only 99% Accurate At-Home Covid & Flu Test

GlobeNewswire August 11, 2022

Lucira Health to Announce Second Quarter 2022 Financial Results

GlobeNewswire August 2, 2022

Lucira Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire August 1, 2022

Lucira Health Announces First Quarter 2022 Results and Business Update

GlobeNewswire May 12, 2022

Lucira Files for Authorization of First-of-its-Kind COVID-19 & Flu At-Home Molecular Test

GlobeNewswire May 12, 2022